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This mutation occurs in 1 of 3500 people worldwide and has the highest new mutation rate among autosomal dominant disorders. 12 In patients with NF1, pheochromocytoma is known to occur at a rate of 0.1% to 5.7%. 12 This incidence increases to 20% to 50% in patients with diagnosed NF1 who also have hypertension. 12 These data are important for primary care physicians because although the mean age of patients receiving a pheochromocytoma diagnosis is 44 years in sporadic cases, the mean age of patients receiving a diagnosis is 25 years in cases with a genetic component (or suspected genetic component). 13 The presence of NF1 makes the diagnosis of pheochromocytoma difficult because NF1-related vasculopathy and renal artery stenosis can lead to vessel changes that will in turn alter the control of blood pressure. Pheochromocytoma in a patient with NF1 will mimic other cardiovascular abnormalities, making diagnosis particularly difficult in patients with comorbid heart conditions.
Early and accurate diagnosis of pheochromocytoma is necessary for successful management and
removal. An updated and more inclusive screening tool for pheochromocytoma is now available to physicians. In 2005, the first international pheochromocytoma symposium generated the following criteria for considering genetic testing: relevant family history; age younger than 35 years; and multifocal, extra-adrenal, or malignant disease.
